The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...

Many public health experts warn of the additive qualities of powerful opioid painkillers. One pharmaceutical company is revealing its new pill that it says does away with those dangers.

What we know after American Airlines plane crashes with Black Hawk helicopter in Washington, D.C.

As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...

Here's what to know about hyperbaric chambers after a 5-year-old boy was killed in an explosion at a healthcare facility in ...

The FDA has recalled Mercury Medical’s Neo-Tee T-Piece Resuscitator, a gas powered resuscitator intended primarily for ...

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

Cal Yee Farm LLC is recalling chocolate and other products. Some have been given a Class I classification by the FDA which is their highest risk level.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.